Autopsy report · NCT01167738

Combination Chemotherapy With or Without Metformin Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“concern of detrimental effect”

The sponsor’s own words in the registry.

Life of this trial

Ran for about 4 years 9 months before it stopped.
60 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 2
Sponsor: IRCCS San Raffaele
Sponsor type: University, hospital or other
Conditions: Pancreatic Cancer
Interventions: capecitabine; cisplatin; epirubicin; gemcitabine; metformin
Participants: 60
Sites: 1
Countries: Italy

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.